Interdisciplinary management of colorectal cancer liver metastases

European Surgery - Acta Chirurgica Austriaca

Volumn 38, Issue 2, 2006, Pages 107-111

  Gruenberger, Thomas ^a,b   Gruenberger, B ^a   Becherer, A ^a   Kettenbach, J ^a   Dieckmann, K ^a   Schima, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Surgery   (Austria)

Author keywords

Colorectal cancer liver metastases; Interdisciplinary therapy; Liver surgery; Neoadjuvant chemotherapy; Oncosurge

Indexed keywords

ADJUVANT CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LIVER METASTASIS; LIVER RESECTION; PATIENT CARE; REVIEW; SURGICAL TECHNIQUE;

EID: 33744923477     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10353-006-0229-9     Document Type: Review

References (30)

1. Grothey A, Sargent D, Goldberg RM, Schmoll HJ (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22: 1209-1214
2. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pilot HC, Alberts SR (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22: 23-30
3. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229-237
4. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O, Levi F, Bismuth H (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240: 644-657
5. Gruenberger T, Schuell B, Puhalla H, Schwanzer E, Bodingbauer M, Laengle F, Kornek G, Scheithauer W (2004) Changes in liver surgery for colorectal cancer liver metastases under neoadjuvant treatment strategies. Eur Surg 36: 317-321
6. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M (2003) One-thousand-and-fifty-six hepatectomies without mortality in 8 years. Arch Surg 138: 1198-1206
7. Kokudo N, Imamura H, Sugawara Y, Sakamoto Y, Yamamoto J, Seki M, Makuuchi M (2004) Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg 11: 84-91
8. Jaeck D, Bachellier P, Nakano H, Oussoultzoglou E, Weber JC, Wolf P, Greget M (2003) One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 185: 221-229
9. Abdalla E, Vauthey J, Ellis L, Ellis V, Pollock R, Broglio K, Hess K, Curley S (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: 818-827
10. Onaitis M, Morse M, Hurwitz H, Cotton P, Tyler D, Clavien P, Clary B (2003) Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 237: 782-788
11. Schmiegel W (2004) S3-guidelines colorectal cancer 2004. Z Gastroenterol 42: 1129-1177
12. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342
13. Folprecht G, Kohne C (2004) The role of new agents in the treatment of colorectal cancer. Oncology 66: 1-17
14. Ruers TJM, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T, Corstens FHM, Oyen WJG (2002) Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20: 388-395
15. Sojar V, Stanisavljevic D, Hribernik M, Fius T, Kreuh D, Velkavrh U (2004) Liver surgery planning in 3D virtual space. HPB 6 (Suppl 1): 179
16. Elias D, Baton O, Sideris L, Matsuhisa T, Pocard M, Lasser P (2004) Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol 11: 500-505
17. Gruenberger T, Morris D (2002) Staged treatment of bilobar hepatic metastases from colorectal cancer. Eur J Surg 168: 516-518
18. Hemming A, Reed A, Howard R, Fujita S, Hochwald S, Caridi J, Hawkins I, Vauthey J (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237: 686-693
19. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A, Bismuth H (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231: 480-486
20. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H (2000) Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 232: 777-785
21. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber J, Bachellier P (2004) A two-stage hepatectmomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240: 1037-1051
22. Fernandez F, Drebin J, Linehan D, Dehdashti F, Siegel B, Strasberg S (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240: 438-447
23. Taieb J, Artru P, Paye F, Louvet C, Perez N, Andre T, Gayet B, Hebbar M, Goebel FM, Tournigand C, Parc R, de Gramont A (2005) Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study. J Clin Oncol 23: 502-509
24. Masi G, Allegrini G, Cupini S, Marcucci L, Cerri E, Brunetti I, Fontana E, Ricci S, Andreuccetti M, Falcone A (2004) First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule. Ann Oncol 15: 1766-1772
25. Di Stefano DR, de Baere T, Denys A, Hakime A, Gorin G, Gillet M, Saric J, Trillaud H, Petit P, Bartoli JM, Elias D, Delpero JR (2005) Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234: 625-630
26. Abitabile P, Hartl U, Maurer CA (2004) The local ablation with radiofrequency enables a safe and efficient treatment of small liver tumors. J Clin Oncol (Meeting Abstracts) 22: 3724
27. Gruenberger T, Schuell B, Kornek G, Scheithauer W (2004) Neoadjuvant chemotherapy for resectable colorectal cancer liver metastases: Impact on magnitude of liver resection and survival. J Clin Oncol (Meeting Abstracts) 22: 3598
28. Quenet F, Nordlinger B, Rivoire M, Delpero JR, Portier G, Mery-Mignard D, Magherini E, Payrard S, Ychou M (2004) Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L-OHP/LV5FU (Folfirinox): A prospective phase II trial. J Clin Oncol (Meeting Abstracts) 22: 3613
29. Tabernero JM, Van Cutsem E, Sastre J, Cervantes A, Van Laethem JL, Humblet Y, Soulie P, Corretge S, Mueser M, De Gramont A (2004) An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR). Preliminary results. J Clin Oncol (Meeting Abstracts) 22: 3512
30. Poston G, Haller D, Kahan J, Cornelis M, Mahyaoui S (2004) Individualizse the treatment of liver metastases from colorectal cancer using RAND appropriateness method: Oncosurge decision model. Results of a consensus detecting from the international taskforce group. J Clin Oncol (Meeting Abstracts) 22: 3595